Tumor infiltrating CD8 + and Foxp3 + Lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in Tonsillar cancer

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Näsman, Anders ^a   Romanitan, Mircea ^a   Nordfors, Cecilia ^a   Grün, Nathalie ^a   Johansson, Hemming ^a   Hammarstedt, Lalle ^b   Marklund, Linda ^b   Munck Wikland, Eva ^b   Dalianis, Tina ^a   Ramqvist, Torbjörn ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD8 ANTIGEN; FORMALDEHYDE; PARAFFIN; TRANSCRIPTION FACTOR FOXP3; TUMOR MARKER; VIRUS DNA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; FEMALE; FOXP3+ T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; REGULATORY T LYMPHOCYTE; TONSIL CANCER; TONSILLAR SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE; WART VIRUS; ALPHAPAPILLOMAVIRUS; IMMUNOLOGY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; SWEDEN; TONSIL TUMOR; VIROLOGY;

ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SWEDEN; TONSILLAR NEOPLASMS; TREATMENT OUTCOME;

EID: 84862174372     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038711     Document Type: Article

References (35)

1. Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, et al. (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126: 2879-2884.
2. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, et al. (2011) Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. J Clin Oncol.
3. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, et al. (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125: 362-366.
4. Ramqvist T, Dalianis T, (2010) Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 16: 1671-1677.
5. Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, et al. (2011) Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer 128: 2892-2897.
6. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, et al. (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269.
7. Lindquist D, Romanitan M, Hammarstedt L, Nasman A, Dahlstrand H, et al. (2007) Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1: 350-355.
8. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E, (2000) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89: 300-304.
9. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
10. Hilders CG, Ras L, van Eendenburg JD, Nooyen Y, Fleuren GJ, (1994) Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int J Cancer 57: 805-813.
11. Bontkes HJ, de Gruijl TD, van den Muysenberg AJ, Verheijen RH, Stukart MJ, et al. (2000) Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia. Int J Cancer 88: 92-98.
12. Welters MJ, van der Logt P, van den Eeden SJ, Kwappenberg KM, Drijfhout JW, et al. (2006) Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease. Int J Cancer 118: 950-956.
13. Nedergaard BS, Ladekarl M, Thomsen HF, Nyengaard JR, Nielsen K, (2007) Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer. Br J Cancer 97: 1135-1138.
14. Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, et al. (2007) High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 67: 354-361.
15. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964.
16. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, et al. (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 102: 18538-18543.
17. Talmadge JE, Donkor M, Scholar E, (2007) Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 26: 373-400.
18. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, et al. (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24: 5373-5380.
19. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, et al. (2003) Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 9: 4404-4408.
20. Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, et al. (2006) Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 12: 465-472.
21. Salama P, Phillips M, Grieu F, Morris M, Zeps N, et al. (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27: 186-192.
22. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, et al. (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119: 2620-2623.
23. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, et al. (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121: 2465-2472.
24. Spanos WC, Nowicki P, Lee DW, Hoover A, Hostager B, et al. (2009) Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol Head Neck Surg 135: 1137-1146.
25. Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, et al. (2006) HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 66: 9281-9289.
26. Heusinkveld M, Goedemans R, Briet RJ, Gelderblom H, Nortier JW, et al. (2011) Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int J Cancer.
27. Shah W, Yan X, Jing L, Zhou Y, Chen H, et al. (2011) A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell Mol Immunol 8: 59-66.
28. Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, et al. (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108: 2957-2964.
29. Babu JM, Prathibha R, Jijith VS, Hariharan R, Pillai MR, (2011) A miR-centric view of head and neck cancers. Biochim Biophys Acta 1816: 67-72.
30. Ferreira MB, De Souza JA, Cohen EE, (2011) Role of molecular markers in the management of head and neck cancers. Curr Opin Oncol 23: 259-264.
31. Lallemant B, Evrard A, Chambon G, Sabra O, Kacha S, et al. (2010) Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives. Head Neck 32: 1712-1719.
32. Leemans CR, Braakhuis BJ, Brakenhoff RH, (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22.
33. Attner P, Nasman A, Du J, Hammarstedt L, Ramqvist T, et al. (2011) Survival in patients with human papillomavirus (HPV) positive tonsillar cancer in relation to treatment. Int J Cancer.
34. Zackrisson B, Nilsson P, Kjellen E, Johansson KA, Modig H, et al. (2011) Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma-the ARTSCAN study. Radiother Oncol 100: 41-48.
35. Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC, (2010) Regulatory T cells in cancer. Adv Cancer Res 107: 57-117.